Brainsway Reports Continued Financial Growth for Q3 of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Brainsway Reports Continued Financial Growth for Q3 of 2016
  • Revenue Increased by 87 percent to $3.4 million compared to Q3 2015
  • Gross profit exceeds 83 percent to approximately $2.8 million compared to Q3 2015
  • Third quarter Non-GAAP dilution of $356,000 compared to $459,000 in Q3 2015
  • Cash flow increases by $60,000 compared to the Q2 2016 cash flow

HACKENSACK, N.J., Nov. 28, 2016 (GLOBE NEWSWIRE) --   Brainsway® USA Inc ., a subsidiary of Brainsway Ltd. (TASE: BRIN ), a leader in the advanced non-invasive treatment of brain disorders, announced today promising Q3 2016 results.  The report shows continuous strong financial performance and the increase is mainly due to the sale of new systems in the U.S. market.

"We continue improving our financial performance quarter over quarter towards profitability. Despite its growing investment in clinical trials, research and development, and marketing, the company managed to decrease its monthly burn rate to less than $120,000 and generate positive cash flow in Q3. Brainsway has enough cash position to execute its strategic plan,” said Hadar Levy, chief financial officer of Brainsway.

Joseph Perekupka, VP of North American Sales Operations said, "Our strategy to focus on the commercialization for the U.S. market is working and our growth exceeds our expectations during Q3 this year.  We are also happy to announce that patient recruitment for our OCD trial will soon be complete. To date, the company has recruited 88 out of a total of 98 patients needed to complete the trial and are preparing to file for FDA clearance in 2017.  Brainsway will strengthen its growth plans with a strong sales force and new regional sales managers. Currently, 85 percent of the American population have insurance coverage for Brainsway's treatment while we continue to obtain clinical data and receive further positive indications in a variety of clinical trials. The company continues to seek collaborations with strategic partners and key opinion leaders in the U.S., as well as medical centers offering Deep TMS."

About Brainsway Brainsway Ltd./ Brainsway USA is a leader in non-invasive treatments for brain disorders utilizing Deep Transcranial Magnetic Stimulation (Deep TMS). Our unique patented technology was developed in collaboration with the National Institute of Health (NIH) and is FDA and CE cleared to treat patients with depression who are not currently responding to medication. The treatment has been enthusiastically supported by many academic communities and is widely covered by most insurance payers. For more information, please visit  www.brainsway.com .

Forward-Looking Statements This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.

Media Contact: Megan Vandenbos megan@antennagroup.com 201-465-8019

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FLUX 3 Max Launches with Unmatched Speed and Quality

Updated Category News Views 14

A Lightning Fast Leap in Video Generation It's all eyes on FLUX 3 Max today. You can almost hear the gasps of 'wow' in the generative media crowd. Why? Because this new weapon in the video gen arsenal, dreamed up by fal and Black Forest Labs, is slicing through the old speed limits like a blistering comet. Now, don't get me wrong. Seeds don't grow overnight, and neither...

Continue Reading
National Showrooms Expands into Virginia with Key Buy

Updated Category News Views 6

A New Chapter for Greenwich Kitchens I'll tell you what's catching my eye this time—National Kitchen & Bath Showrooms are making their move into Virginia by snapping up Greenwich Kitchens, a well-regarded name in the local kitchen and bath scene. Founded back in '78, Greenwich Kitchens has been a staple in the Virginia Beach and Hampton Roads areas for nearly half a...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 9

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
LBT Unveils Game-Changing Cyclotron for Medical Advances

Updated Category News Views 9

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Continue Reading
AppLovin Faces Securities Fraud Lawsuit Amid AI Claims

Updated Category News Views 6

Digging Into AppLovin's Legal Turmoil Well, it's another wrinkle in the markets' many lines. This time, we’ve got AppLovin Corporation facing the music with a securities fraud lawsuit. If you’ve got shares in NASDAQ:APP, you might want to perk up. Let the trial by fire begin, I say. The Lawsuit Details & Class Period Here we are, October 19, 2026, and the legal eagles...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 23

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Ruth E. Carter Returns Home with Celebrated Exhibition

Updated Category News Views 8

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Continue Reading
Alaska LNG Project Boosted by Strategic Positioning

Updated Category News Views 6

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Continue Reading
New JPA Aims to Energize Inland Empire's Water Supply

Updated Category News Views 24

Fresh Steps in San Bernardino's Infrastructure Strategy Here's a twist for you: public agencies in San Bernardino County decided enough with the same old, same old and cooked up a new joint powers authority (JPA). They call it the San Bernardino Water and Power Authority, which sounds snappy enough for a meeting room nameplate, I reckon. Who's Steering the Ship? Leading...

Continue Reading
Nest Health Appoints Peter Morrison for Multistate Expansion

Updated Category News Views 10

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Shipbroking: How AI is Navigating Change and Growth

Updated Category News Views 573

Understanding the Shipbroking Market's Growth The shipbroking market is set to expand significantly, with projections indicating a growth of USD 263.7 million from 2024 to 2028. This growth is largely fueled by advances in technology and the adoption of innovation, highlighting a trend characterized by enhanced efficiency and value creation within shipping processes....

Continue Reading
Kelun-Biotech Reports Impressive Revenue Growth for 2025

Updated Category News Views 242

Kelun-Biotech's Interim Results Highlight Growth Sichuan Kelun-Biotech Pharmaceutical Co., Ltd. recently shared its compelling interim results, showcasing impressive financial performance and significant advancements in its drug pipeline for the first half of 2025. Financial Performance Overview In this reporting period, revenue reached approximately RMB950.4 million,...

Continue Reading
Ingram Micro's Road to a Successful U.S. IPO Under Platinum Equity

Updated Category News Views 341

Ingram Micro made waves back in 2023 with its U.S. IPO filing, shaking off the dust from being bought by Platinum Equity for a whopping $7.2 billion in 2021. This wasn’t just a casual stroll down memory lane; it was a strategic pivot as they geared up to re-enter the stock market after over two years in the private equity shadows. What Drove Ingram Micro's IPO Move?...

Continue Reading
Rapid Spread of Hughes Fire Challenges Firefighters in California

Updated Category News Views 226

Brush Fire Emerges in Northern Los Angeles County A brush fire has ignited and expanded rapidly in the Castaic region of northern Los Angeles County. Dubbed the Hughes Fire, it has covered a staggering area exceeding 3,400 acres, according to recent reports from various sources. Initial Response and Fire Development The fire broke out around 11 a.m. near Lake Hughes Road,...

Continue Reading
Stifel Analyst Sets $82 Price Target for Solventum with Buy Rating

Updated Category News Views 74

Stifel Initiates Coverage on Solventum In a significant move, Stifel has initiated coverage on Solventum (NYSE: SOLV), a versatile MedTech company, granting it a Buy rating along with a price target set at $82. Following its recent emergence as an independent entity through a spin-off, Solventum boasts a market capitalization of around $8.2 billion. The company operates...

Continue Reading